Home/Filings/4/0000950170-24-009002
4//SEC Filing

White Marvin L 4

Accession 0000950170-24-009002

CIK 0001671584other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 6:02 PM ET

Size

6.8 KB

Accession

0000950170-24-009002

Insider Transaction Report

Form 4
Period: 2024-01-28
White Marvin L
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-28+4,79244,929 total
  • Exercise/Conversion

    Restricted Stock Unit

    2024-01-284,7920 total
    Common Stock (4,792 underlying)
Footnotes (2)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]On January 29, 2021, the reporting person was granted 14,375 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022.

Documents

1 file

Issuer

Aptevo Therapeutics Inc.

CIK 0001671584

Entity typeother

Related Parties

1
  • filerCIK 0001493324

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 6:02 PM ET
Size
6.8 KB